You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.


The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
 

You are reading 1 of 2 free-access articles allowed for 30 days

Ulster University part of £750,000 CF-related diabetes study

By Mindo - 05th Aug 2016 | 2 views

Ulster University will play a key role in the research, which is being led by Newcastle University (UK) in partnership with Lund University (Sweden), The University of Iowa (USA) and Szeged University (Hungary).

“Discovering how the defective cystic fibrosis gene affects the body’s ability to regulate insulin levels is crucial to working out how to prevent diabetes from developing in CF sufferers,” said Dr Catriona Kelly from Ulster University.

“This new research brings CF and diabetes specialists together for the first time to identify crucial new treatment options that could enable the majority of CF patients to live longer and healthier lives.

“Ulster University’s specialist expertise in personalised medicine research carried out at our C-TRIC facility in Altnagelvin will be integral to the study.”

Approximately 20 per cent of adolescents and 50 per cent of adults living with CF have diabetes, and the condition can have a detrimental impact on lung function and wider health.

Known as Cystic fibrosis-related diabetes (CFRD), it is a unique condition. While the cause is unknown, the development of the diabetes accelerates lung disease, which is the main reason for death among people with CF.

Leave a Reply

Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read